Emily Field, Barclacys head of European pharmaceuticals equity research, joins ‘Squawk Box’ to discuss Novo Nordisk’s quarterly earnings results, impact of copycat compounded drugs on Wegovy sales, state of the obesity drug competition, impact of tariffs, and more.
